Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

246 Press Releases
DateTitleCompany
24 Apr 13 Sanofi Pasteur to Provide 1.7 Billion Doses of Oral Polio Vaccine from 2013 to 2017 for Polio Eradication Sanofi Pasteur
24 Apr 13 Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2013 Earnings Per Share of $0.17 Including $0.08 Per Share of Acquisition Amortization Forest Laboratories, Inc
23 Apr 13 Global agro-industry working together to drive the world towards sustainable food and water production CropWorld Global 2013 ,
Published by
De Facto Communications
22 Apr 13 Science Warehouse and One MRO partner to provide integrated inventory management and e-procurement capability for MRO operations Science Warehouse
22 Apr 13 NICE issues latest draft guidance on bevacizumab for recurrent advanced ovarian cancer NICE
22 Apr 13 AstraZeneca and BIND Therapeutics announce worldwide development and commercialisation agreement for cancer nanomedicine AstraZeneca
22 Apr 13 Hexyon/Hexacima 6-in -1 Pediatric Vaccine Approved in Europe Sanofi
22 Apr 13 Alcon announces FDA approval of Simbrinza(TM) Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients Novartis
19 Apr 13 New Vertex research shows strong results for potential therapy for most common CF mutation Cystic Fibrosis Trust
18 Apr 13 Sanofi reinforces its presence in Morocco Sanofi
18 Apr 13 Open for Entry - The PM Society Digital Media Awards 2013 PM Society
18 Apr 13 CPhI South East Asia indicates rapid pharma sector growth for the ASEAN CPhI,
Published by
De Facto Communications
18 Apr 13 Roche and Ascletis enter collaboration to advance treatment options for Chinese patients with Hepatitis C Roche
18 Apr 13 New type of bowel cancer discovered Cancer Research UK
17 Apr 13 Mercodia AB announces the signing of exclusive C-PEP3 licensing agreement with SBH Diagnostic Inc Mercodia AB
15 Apr 13 Chinese Group Makes Strategic Investment in Yonkers Biotechnology Company ContraFect,
Published by
AXON
15 Apr 13 CPhI and PharmaEvolution.com to analyze pharma industry in monthly and annual reports CPhI and PharmaEvolution.com ,
Published by
DeFacto
12 Apr 13 Sanofi and PATH announce the Launch of Large-scale Production of Semisynthetic Artemisinin against Malaria Sanofi
12 Apr 13 Bristol-Myers Squibb Foundation, Morehouse School of Medicine Partner to Spread Lessons from Together on Diabetes™ Initiative Bristol-Myers Squibb
12 Apr 13 NICE seeks views on draft guidance for non-Hodgkin's lymphoma treatment NICE
12 Apr 13 Draft guidance from NICE says yes to ranibizumab for common eye condition NICE
12 Apr 13 Sanofi Pasteur’s New Quadrivalent Influenza Vaccine Accepted for Review for European Approval Sanofi Pasteur
12 Apr 13 Merck Announces FDA Acceptance of New Drug Application for an Investigational Tablet Formulation of the Antifungal NOXAFIL® (posaconazole) Merck
12 Apr 13 Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient Abbott
12 Apr 13 Actavis Reaches Agreements with Valeant to Launch Generic Versions of Ziana® and Zyclara® Actavis, Inc
12 Apr 13 Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress Society for Brain Mapping and Therapeutics (SBMT)
10 Apr 13 Mercodia and Profil Institute Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials Mercodia AB
10 Apr 13 ARIAD PRESENTS NEW PRECLINICAL DATA SHOWING PONATINIB OVERCOMES RESISTANT MUTATIONS IN KIT, AN ONCOGENIC DRIVER OF GASTROINTESTINAL STROMAL TUMORS ARIAD Pharmaceuticals, Inc,
Published by
Biosector 2
08 Apr 13 New PDUFA action date announced by the US FDA for Injectafer® New Drug Application Vifor Pharma ,
Published by
Vifor Pharma
08 Apr 13 Lundbeck announces positive results for Brintellix™ (vortioxetine) in adult patients with major depression and inadequate response to SSRI or SNRI therapy H. Lundbeck A/S,
Published by
Lundbeck
Advertising